Navigator Medicines, Inc.

🗓 Founded 2024👥 12 employees💰 Last funded Aug 2024
Biotechnology Research🌐 navigatormedicines.com
Website LinkedIn
Navigator Medicines is a clinical-stage biopharmaceutical company leading the advancement of biologics for targeted immune regulation & restoration. Founded in 2024, as a subsidiary of Sera Medicines, through a $100M Series A financing, co-led by RA Capital Management and Forbion, the Company is committed to developing new therapies for patients living with complex, heterogeneous autoimmune diseases.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Navigator Medicines, Inc.?
Navigator Medicines, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Navigator Medicines, Inc. last raise funding?
The most recent investment in Navigator Medicines, Inc. recorded on gritt.io was in August 2024.
When was Navigator Medicines, Inc. founded?
Navigator Medicines, Inc. was founded in 2024.
What industry is Navigator Medicines, Inc. in?
Navigator Medicines, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.